Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Parathyroid carcinoma is a rare cause for primary hyperparathyroidism. A 65-yr-old man presented with postoperative, recurrent hyperparathyroidism after resection of parathyroid carcinoma. Misleading findings were demonstrated by both double-phase 99mTc-sestamibi scintigraphy and MRI. The location and extent of the parathyroid carcinoma were correctly detected by PET using 18F-fluorodeoxyglucose. FDG-PET provided accurate information before reoperation and proved to be valuable for preoperative surgical planning.
Neumann
D R
DR
Department of Nuclear Medicine, Cleveland Clinic Foundation, Ohio 44195, USA.
Esselstyn
C B
CB
Kim
E Y
EY
D000368:Aged; D002277:Carcinoma / Q000150:complications / Q000000981:diagnostic imaging / Q000601:surgery; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D006961:Hyperparathyroidism / Q000209:etiology; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D010282:Parathyroid Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000601:surgery; D017256:Technetium Tc 99m Sestamibi; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon
D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D017256:Technetium Tc 99m Sestamibi; D003847:Deoxyglucose